These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21266550)

  • 1. Observing pretibial myxedema in patients with Graves' disease using digital infrared thermal imaging and high-resolution ultrasonography: for better records, early detection, and further investigation.
    Shih SR; Lin MS; Li HY; Yang HY; Hsiao YL; Chang MT; Chen CM; Chang TC
    Eur J Endocrinol; 2011 Apr; 164(4):605-11. PubMed ID: 21266550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretibial myxedema without ophthalmopathy: an initial presentation of Graves' disease.
    Lohiya S; Lohiya V; Stahl EJ
    Am J Med Sci; 2013 Jul; 346(1):73-5. PubMed ID: 23514670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretibial myxedema as the initial manifestation of Graves' disease.
    Georgala S; Katoulis AC; Georgala C; Katoulis EC; Hatziolou E; Stavrianeas NG
    J Eur Acad Dermatol Venereol; 2002 Jul; 16(4):380-3. PubMed ID: 12224697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multipoint subcutaneous injection of long-acting glucocorticid as a cure for pretibial myxedema.
    Deng A; Song D
    Thyroid; 2011 Jan; 21(1):83-5. PubMed ID: 21162684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretibial myxedema and high-dose intravenous immunoglobulin treatment.
    Antonelli A; Navarranne A; Palla R; Alberti B; Saracino A; Mestre C; Roger P; Agostini S; Baschieri L
    Thyroid; 1994; 4(4):399-408. PubMed ID: 7711502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of pretibial myxedema with dexamethazone injected subcutaneously by mesotherapy needles.
    Vannucchi G; Campi I; Covelli D; Forzenigo L; Beck-Peccoz P; Salvi M
    Thyroid; 2013 May; 23(5):626-32. PubMed ID: 23397966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretibial myxedema in a euthyroid patient.
    Anagnostis P; Artzouchaltzi A; Grekou A; Paschou SA; Gerou S; Tzalokostas V
    Hormones (Athens); 2018 Mar; 17(1):133-135. PubMed ID: 29858862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The application of temperature measurement of the eyes by digital infrared thermal imaging as a prognostic factor of methylprednisolone pulse therapy for Graves' ophthalmopathy.
    Shih SR; Li HY; Hsiao YL; Chang TC
    Acta Ophthalmol; 2010 Aug; 88(5):e154-9. PubMed ID: 20553230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Echographic diagnosis of pretibial myxedema in patients with autoimmune thyroid disease.
    Salvi M; De Chiara F; Gardini E; Minelli R; Bianconi L; Alinovi A; Ricci R; Neri F; Tosi C; Roti E
    Eur J Endocrinol; 1994 Aug; 131(2):113-9. PubMed ID: 8075779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of Pretibial Myxedema Following Administration of Teprotumumab.
    Washington A; Nam H; Pitch M; Anderson B; Stokes J; Helm M
    J Drugs Dermatol; 2022 Nov; 21(11):1252-1254. PubMed ID: 36342728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pretibial myxedema: pathogenetic features and clinical aspects].
    Sabanova EA; Fadeyev VV; Potekaev NN; Lvov AN
    Probl Endokrinol (Mosk); 2019 Jun; 65(2):134-138. PubMed ID: 31271716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Graves' dermopathy a generalized disorder?
    Peacey SR; Flemming L; Messenger A; Weetman AP
    Thyroid; 1996 Feb; 6(1):41-5. PubMed ID: 8777383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Tc-99m DTPA uptake in active Graves' ophthalmopathy and pretibial myxoedema.
    Alevizaki-Harhalaki M; Alevizaki C; Georgiou E; Proukauis C; Ikkos D
    J Nucl Med; 1983 Feb; 24(2):174-6. PubMed ID: 6337239
    [No Abstract]   [Full Text] [Related]  

  • 14. [Graves' disease (clinical aspects of Graves' disease)].
    Iitaka M
    Nihon Rinsho; 1999 Aug; 57(8):1755-8. PubMed ID: 10483245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower extremity manifestations of Graves' disease.
    Sauer P; Brandes B; Mahmarian RR
    J Foot Ankle Surg; 1995; 34(5):489-97. PubMed ID: 8590885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elephantiasic pretibial myxedema and cutis verticis gyrata caused by Graves' disease.
    Bilen H; Atasoy M; Akcay G; Akcay M; Capoglu I; Gursan N; Akbas M
    Thyroid; 2006 Aug; 16(8):815-6. PubMed ID: 16910888
    [No Abstract]   [Full Text] [Related]  

  • 17. Computed tomography and magnetic resonance imaging findings of ureteral myxedema in Graves' disease.
    Minutoli F; Benedetto C; Visalli C; Granata A; Gaeta M
    Clin Imaging; 2015; 39(4):711-3. PubMed ID: 25766333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TSH receptor transcripts and TSH receptor-like immunoreactivity in orbital and pretibial fibroblasts of patients with Graves' ophthalmopathy and pretibial myxedema.
    Stadlmayr W; Spitzweg C; Bichlmair AM; Heufelder AE
    Thyroid; 1997 Feb; 7(1):3-12. PubMed ID: 9086563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localized myxedema of the toe: a rare presentation of graves' dermopathy.
    Hasani-Ranjbar S; Mohajeri-Tehrani MR
    Arch Iran Med; 2008 May; 11(3):326-9. PubMed ID: 18426326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A woman with red, swollen lower legs].
    Siemerink M; van Praag MC
    Ned Tijdschr Geneeskd; 2010; 154():A1186. PubMed ID: 20977783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.